These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3124179)

  • 1. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse.
    Bradbury AJ; Costall B; Naylor RJ; Onaivi ES
    Psychopharmacology (Berl); 1987; 93(4):457-65. PubMed ID: 3124179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity to d- and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity.
    Lucki I; Harvey JA
    Neuropharmacology; 1979 Mar; 18(3):243-9. PubMed ID: 571542
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of adenine-induced depression of mouse locomotor activity by amphetamine.
    Akintonwa A; Auditore JV
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):248-53. PubMed ID: 736702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When injected into the fimbria-fornix/cingular bundle, not in the raphe, 5,7-dihydroxytryptamine prevents amphetamine-induced hyperlocomotion.
    Lehmann O; Jeltsch H; Bertrand F; Lazarus C; Will B; Cassel J
    Behav Brain Res; 2000 Sep; 114(1-2):213-7. PubMed ID: 10996062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic dorsal raphe neurons: changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration.
    Heidenreich BA; Rebec GV
    Neurosci Lett; 1989 Aug; 103(1):81-6. PubMed ID: 2779857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of neuronal elements within the median nucleus of the raphe that mediate lesion-induced increases in locomotor activity.
    Asin KE; Fibiger HC
    Brain Res; 1983 Jun; 268(2):211-23. PubMed ID: 6871682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic dorsal raphe neurons: subsensitivity to amphetamine with long-term treatment.
    Heidenreich BA; Basse-Tomusk AE; Rebec GV
    Neuropharmacology; 1987 Jul; 26(7A):719-24. PubMed ID: 3627380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.
    Kusljic S; Copolov DL; van den Buuse M
    Neuropsychopharmacology; 2003 Dec; 28(12):2138-47. PubMed ID: 12888784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of destruction of midbrain raphe nuclei on the behavioral effects of dopaminergic substances and I-tryptophan].
    Allikmets LKh; Zharkovskiĭ AM; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(5):1030-5. PubMed ID: 563144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion.
    Layer RT; Uretsky NJ; Wallace LJ
    Life Sci; 1992; 50(11):813-20. PubMed ID: 1740965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions.
    Fletcher PJ; Korth KM; Chambers JW
    Psychopharmacology (Berl); 1999 Sep; 146(2):185-93. PubMed ID: 10525754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.
    Kusljic S; Brosda J; Norman TR; van den Buuse M
    Brain Res; 2005 Jul; 1049(2):217-26. PubMed ID: 15953591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei.
    Nicolaou NM; Garcia-Munoz M; Arbuthnott GW; Eccleston D
    Eur J Pharmacol; 1979 Aug; 57(4):295-305. PubMed ID: 573694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine.
    Olds ME; Yuwiler A
    Eur J Pharmacol; 1992 Jun; 216(3):363-72. PubMed ID: 1425928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.
    Hollister AS; Breese GR; Kuhn CM; Cooper BR; Schanberg SM
    J Pharmacol Exp Ther; 1976 Jul; 198(1):12-22. PubMed ID: 132524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat.
    Herges S; Taylor DA
    Eur J Pharmacol; 1999 Jun; 374(3):329-40. PubMed ID: 10422777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destruction of serotonergic neurons in the median raphe nucleus blocks circadian rhythm phase shifts to triazolam but not to novel wheel access.
    Meyer-Bernstein EL; Morin LP
    J Biol Rhythms; 1998 Dec; 13(6):494-505. PubMed ID: 9850010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.